Senior Territory Business Manager, Hematology - Seattle S at Bristol-Myers Squibb

Spokane, Washington, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, HealthcareIndustries

Requirements

Field-based role requiring 100% time spent with external customers in the territory (Seattle, Spokane WA, Missoula, Billings MT)
High level of scientific expertise in assigned products and therapeutic areas (hematology)
Ability to engage HCPs with differentiated Customer Experience (Cx) through deeper scientific dialogue consistent with label
Builds and maintains strong professional credibility with regional thought leaders (RTLs), community-based physicians/HCPs, private practices, medical groups, office staff, and stakeholders
Prepares and implements comprehensive territory and account plans
Proactively uses tools like CE^3 to derive insights, inform call plans, and provide feedback for improvement
Demonstrates scientific expertise using approved resources and publications, ensuring medical accuracy
Conducts in-office presentations (e.g., lunch and learns)
Prioritizes safe and appropriate use of BMS products while focusing on business results and exemplifying BMS values
Liaises with other BMS functions to deliver higher Customer Experience by meeting HCP needs timely and scientifically

Responsibilities

Promotes approved indications of BMS products within defined territory/region to meet or exceed sales targets in a compliant manner
Creates demand for BMS medicines by articulating clinical and scientific rationale for use in appropriate patients in a balanced manner
Engages with and continuously maintains/grows scientific expertise in all assigned products and therapeutic areas
Prepares and successfully implements comprehensive territory and account plans
Proactively uses available tools such as CE^3 to derive insights and dynamically inform call plans; provides feedback to leadership
Demonstrates scientific expertise and passion in fair & balanced scientific dialogue using approved resources
Drives demand for BMS medicines within portfolio for appropriate patients
Delivers impactful engagement with HCPs to drive adoption of new and existing medicines
Focuses on overall business results and performance objectives while prioritizing safe product use

Skills

Pharmaceutical Sales

Territory Management

Hematology

HCP Engagement

Oncology

Immunology

Sales Strategy

Account Management

BioPharma

Customer Engagement

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free